- Home
- TYL vs KRYS Comparison
TYL vs KRYS Comparison
Compare TYL & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TYL | KRYS |
|---|---|---|
| Founded | 1966 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 10.3B |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TYL | KRYS |
|---|---|---|
| Price | $313.74 | $363.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $476.50 | $297.60 |
| AVG Volume (30 Days) | ★ 799.8K | 325.6K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.01 | ★ 128.00 |
| EPS | ★ 1.88 | 1.83 |
| Revenue | ★ $493,101,000.00 | $389,130,000.00 |
| Revenue This Year | $9.55 | $38.74 |
| Revenue Next Year | $9.75 | $32.53 |
| P/E Ratio | ★ $164.61 | $199.89 |
| Revenue Growth | 18.35 | ★ 33.94 |
| 52 Week Low | $270.71 | $130.50 |
| 52 Week High | $621.34 | $382.54 |
Technical Indicators
Market Signals| Indicator | TYL | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 60.90 |
| Support Level | $289.04 | $253.89 |
| Resistance Level | $331.23 | $382.54 |
| Average True Range (ATR) | 11.23 | 13.10 |
| MACD | 3.06 | -1.70 |
| Stochastic Oscillator | 68.54 | 58.14 |
Price Performance
Historical ComparisonAbout TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.